National and international developments in cancer, health and policy. Produced in collaboration with the Press Association unless otherwise stated.
A new study has estimated the ages at which women with faults in two particular genes are most at risk of developing breast and ovarian cancer.
Scientists have developed a blood test that could help doctors select the best treatment for men with aggressive prostate cancer.
The drug trastuzumab emtansine (Kadcyla) will soon be routinely available for patients in England with an advanced type of breast cancer.
A certain group of genetic faults could be used to help predict if immunotherapy will work in cancer patients, according to a new US study.
Using two immunotherapy drugs together could help treat some patients with an aggressive form of breast cancer, according to an Australian study.